158 related articles for article (PubMed ID: 26904317)
41. Erythrocyte Na+,K+-ATPase and nasal potential in pseudohypoaldosteronism.
Bistritzer T; Kerem E; Berkovitch M; Rapoport MJ; Evans S; Aladjem M
Clin Endocrinol (Oxf); 2002 May; 56(5):575-80. PubMed ID: 12030906
[TBL] [Abstract][Full Text] [Related]
42. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
Schweiger B; Moriarty MW; Cadnapaphornchai MA
Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
[TBL] [Abstract][Full Text] [Related]
43. Pseudohypoaldosteronism Type 1 Newborn Patient with a Novel Mutation in
Seyhanli M; Ilhan O; Gumus E; Bor M; Karaca M
J Pediatr Intensive Care; 2020 Jun; 9(2):145-148. PubMed ID: 32351772
[TBL] [Abstract][Full Text] [Related]
44. Pseudohypoaldosteronism: report of a case presenting as failure to thrive.
Buzi F; Bezante T; Brunori A; Notarangelo LD; Ugazio AG
J Pediatr Endocrinol Metab; 1995; 8(1):61-5. PubMed ID: 7584700
[TBL] [Abstract][Full Text] [Related]
45. Hyperkalemic cardiac arrest successfully reversed by hemodialysis during cardiopulmonary resuscitation: case report.
Kao KC; Huang CC; Tsai YH; Lin MC; Tsao TC
Chang Gung Med J; 2000 Sep; 23(9):555-9. PubMed ID: 11092145
[TBL] [Abstract][Full Text] [Related]
46. Life threatening hyperkalemia treated with prolonged continuous insulin infusion.
Awlad Thani S; Al Farsi M; Al Omrani S
Int J Pediatr Adolesc Med; 2019 Sep; 6(3):118-120. PubMed ID: 31700971
[TBL] [Abstract][Full Text] [Related]
47. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1.
Dogan CS; Erdem D; Mesut P; Merve A; Sema A; Iffet B; Afig B
J Pediatr Endocrinol Metab; 2012; 25(9-10):1035-9. PubMed ID: 23426840
[TBL] [Abstract][Full Text] [Related]
48. Rare causes of acute hyperkalemia in the 1st week of life. Three case reports.
Giapros VI; Tsatsoulis AA; Drougia EA; Kollios KD; Siomou EC; Andronikou SK
Pediatr Nephrol; 2004 Sep; 19(9):1046-9. PubMed ID: 15179565
[TBL] [Abstract][Full Text] [Related]
49. [Pseudohypoaldosteronism--renal salt loss syndrome. Therapy and course exemplified by 2 siblings].
Butenandt I; Dörr HG; Kuhnle U
Monatsschr Kinderheilkd; 1986 Aug; 134(8):544-6. PubMed ID: 2945988
[TBL] [Abstract][Full Text] [Related]
50. Case report: Life threatening hyponatremia in infants with urinary tract infections: two cases of type III pseudohypoaldosteronism and review of the literature.
Carl C; Dinkelbach L; Mohr J; Perez R; Vera Lopez T; Fricke-Otto S; Niehues T
Front Pediatr; 2023; 11():1233205. PubMed ID: 38250595
[TBL] [Abstract][Full Text] [Related]
51. Congenital primary adrenal insufficiency and selective aldosterone defects presenting as salt-wasting in infancy: a single center 10-year experience.
Bizzarri C; Olivini N; Pedicelli S; Marini R; Giannone G; Cambiaso P; Cappa M
Ital J Pediatr; 2016 Aug; 42(1):73. PubMed ID: 27485500
[TBL] [Abstract][Full Text] [Related]
52. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
Bonny O; Knoers N; Monnens L; Rossier BC
Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
[TBL] [Abstract][Full Text] [Related]
53. Case Report: Newborns With Pseudohypoaldosteronism Secondary to Excessive Gastrointestinal Losses Through High Output Stoma.
Ou CY; Chen YJ; Lin GB; Chen MF; Chia ST
Front Pediatr; 2021; 9():773246. PubMed ID: 34869126
[TBL] [Abstract][Full Text] [Related]
54. Pseudohypoaldosteronism in a newborn male with functional polymorphisms in the mineralocorticoid receptor genes.
Jeong HA; Park YK; Jung YS; Nam MH; Nam HK; Lee KH; Rhie YJ
Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):230-4. PubMed ID: 26817011
[TBL] [Abstract][Full Text] [Related]
55. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects.
Hanukoglu A
J Clin Endocrinol Metab; 1991 Nov; 73(5):936-44. PubMed ID: 1939532
[TBL] [Abstract][Full Text] [Related]
56. Hook effect: a pitfall leading to misdiagnosis of hypoaldosteronism in an infant with pseudohypoaldosteronism.
Akin L; Kurtoglu S; Kendirci M; Akin MA; Hartmann MF; Wudy SA
Horm Res Paediatr; 2010; 74(1):72-5. PubMed ID: 20431271
[TBL] [Abstract][Full Text] [Related]
57. Salt-losing crisis in infants-not always of adrenal origin.
Pai B; Shaw N; Högler W
Eur J Pediatr; 2012 Feb; 171(2):317-21. PubMed ID: 21833495
[TBL] [Abstract][Full Text] [Related]
58. Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B.
Saffari F; Bahadoran E; Homaei A; Moghbelinejad S
J Pediatr Endocrinol Metab; 2024 Jul; ():. PubMed ID: 38963175
[TBL] [Abstract][Full Text] [Related]
59. [Neonatal pseudohypoaldosteronism: when a denied truth can delay a diagnosis].
Bagna R; Tonetto P; Spola R; Martano C; Ferrero L; Becchino L; Nicocia M; Ciaccia R; Giuliano V; Lala R; Fabris C
Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():769-71. PubMed ID: 11424844
[TBL] [Abstract][Full Text] [Related]
60. Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II.
Erdoğan G; Corapçioğlu D; Erdoğan MF; Hallioğlu J; Uysal AR
J Endocrinol Invest; 1997 Dec; 20(11):681-4. PubMed ID: 9492109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
